{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T06:16:50Z","timestamp":1787984210995,"version":"build-2784847793"},"reference-count":39,"publisher":"Medical Association of Nippon Medical School","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nippon Med Sch"],"published-print":{"date-parts":[[2026,8,20]]},"DOI":"10.1272\/jnms.jnms.2026_93-411","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T22:13:32Z","timestamp":1787609612000},"page":"323-332","source":"Crossref","is-referenced-by-count":0,"title":["Pregnancy Transiently Normalized Platelet Counts in Essential Thrombocytosis"],"prefix":"10.1272","volume":"93","author":[{"given":"Shunsuke","family":"Homma","sequence":"first","affiliation":[{"name":"Department of Hematology, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Wakita","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Sakaguchi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Yui","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koiti","family":"Inokuchi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"21","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Hultcrantz M, Kristinsson SY, Andersson TM, et al. Patterns of survival among patients with myeloproliferative neoplasms diagnosed in Sweden from 1973 to 2008: a population-based study. J Clin Oncol. 2012 Aug 20;30 (24):2995\u20133001.","DOI":"10.1200\/JCO.2012.42.1925"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Chim CS, Kwong YL, Lie AK, et al. Long-term outcome of 231 patients with essential thrombocythemia: prognostic factors for thrombosis, bleeding, myelofibrosis, and leukemia. Arch Intern Med. 2005 Dec 12\u201326;165 (22):2651\u20138.","DOI":"10.1001\/archinte.165.22.2651"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Cheung B, Radia D, Pantelidis P, et al. The presence of the JAK2 V617F mutation is associated with a higher haemoglobin and increased risk of thrombosis in essential thrombocythaemia. Br J Haematol. 2006 Jan;132 (2):244\u20135.","DOI":"10.1111\/j.1365-2141.2005.05858.x"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Barbui T, Finazzi G, Carobbio A, et al. Development and validation of an International Prognostic Score of thrombosis in World Health Organization\u2013essential thrombocythemia (IPSET-thrombosis). Blood. 2012 Dec 20;120 (26):5128\u201333.","DOI":"10.1182\/blood-2012-07-444067"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Finazzi G, Harrison C. Essential thrombocythemia. Semin Hematol. 2005 Oct;42 (4):230\u20138.","DOI":"10.1053\/j.seminhematol.2005.05.022"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Alimam S, Bewley S, Chappell LC, et al. Pregnancy outcomes in myeloproliferative neoplasms: UK prospective cohort study. Br J Haematol. 2016 Oct;175 (1):31\u20136.","DOI":"10.1111\/bjh.14289"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Iskender D, Yilmaz-Ergani S, Aksoy M, et al. High rate of obstetric complications in patients with essential thrombocythemia. Cureus. 2021 Dec 15;13 (12):e20449.","DOI":"10.7759\/cureus.20449"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Nybo Andersen AM, Wohlfahrt J, Christens P, Olsen J, Melbye M. Maternal age and fetal loss: population based register linkage study. BMJ. 2000 June 24;320 (7251):1708\u201312.","DOI":"10.1136\/bmj.320.7251.1708"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Sugiura-Ogasawara M, Suzuki S, Ozaki Y, Katano K, Suzumori N, Kitaori T. Frequency of recurrent spontaneous abortion and its influence on further marital relationship and illness: the Okazaki Cohort Study in Japan. J Obstet Gynaecol Res. 2013 Jan;39 (1):126\u201331.","DOI":"10.1111\/j.1447-0756.2012.01973.x"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Morita K, Ono Y, Takeshita T, et al. Risk factors and outcomes of recurrent pregnancy loss in Japan. J Obstet Gynaecol Res. 2019 Oct;45 (10):1997\u20132006.","DOI":"10.1111\/jog.14083"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Meroni PL, Borghi MO, Raschi E, Tedesco F. Pathogenesis of antiphospholipid syndrome: understanding the antibodies. Nat Rev Rheumatol. 2011 Jun;7 (6):330\u20139.","DOI":"10.1038\/nrrheum.2011.52"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Rolnik DL, Wright D, Poon LC, et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med. 2017 Aug 17;377 (7):613\u201322.","DOI":"10.1056\/NEJMoa1704559"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Maze D, Kazi S, Gupta V, et al. Association of treatments for myeloproliferative neoplasms during pregnancy with birth rates and maternal outcomes: a systematic review and meta-analysis. JAMA Netw Open. 2019 Oct 2;2 (10):e1912666.","DOI":"10.1001\/jamanetworkopen.2019.12666"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Harrison CN, Bareford D, Butt N, et al. Guideline for investigation and management of adults and children presenting with a thrombocytosis. Br J Haematol. 2010 May;149 (3):352\u201375.","DOI":"10.1111\/j.1365-2141.2010.08122.x"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Mesa RA, Jamieson C, Bhatia R, et al. NCCN guidelines insights: myeloproliferative neoplasms, version 2.2018. J Natl Compr Canc Netw. 2017 Oct;15 (10):1193\u2013207.","DOI":"10.6004\/jnccn.2017.0157"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Gangat N, Wolanskyj AP, Schwager S, Tefferi A. Predictors of pregnancy outcome in essential thrombocythemia: a single institution study of 63 pregnancies. Eur J Haematol. 2009 May;82 (5):350\u20133.","DOI":"10.1111\/j.1600-0609.2009.01214.x"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Pagliaro P, Arrigoni L, Muggiasca ML, Poggio M, Russo U, Rossi E. Primary thrombocythemia and pregnancy: treatment and outcome in fifteen cases. Am J Hematol. 1996 Sep;53 (1):6\u201310.","DOI":"10.1002\/(SICI)1096-8652(199609)53:1<6::AID-AJH2>3.0.CO;2-V"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Griesshammer M, Struve S, Barbui T. Management of Philadelphia negative chronic myeloproliferative disorders in pregnancy. Blood Rev. 2008 Sep;22 (5):235\u201345.","DOI":"10.1016\/j.blre.2008.03.007"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Gangat N, Tefferi A. Myeloproliferative neoplasms and pregnancy: overview and practice recommendations. Am J Hematol. 2021 Mar 1;96 (3):354\u201366.","DOI":"10.1002\/ajh.26067"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Reese JA, Peck JD, Deschamps DR, et al. Platelet counts during pregnancy. N Engl J Med. 2018 Jul;379 (1):32\u201343.","DOI":"10.1056\/NEJMoa1802897"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Wright CA, Tefferi A. A single institutional experience with 43 pregnancies in essential thrombocythemia. Eur J Haematol. 2001 Mar;66 (3):152\u20139.","DOI":"10.1034\/j.1600-0609.2001.00367.x"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Al-Mashdali AF, Yassin MA. Rebound of platelet count in a patient with type 2 calreticulin-mutant essential thrombocythemia in the postpartum period: a case report. Medicine (Baltimore). 2021 Nov 5;100 (44):e27725.","DOI":"10.1097\/MD.0000000000027725"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Bangerter M, Guthner C, Beneke H, Hildebrand A, Grunewald M, Griesshammer M. Pregnancy in essential thrombocythaemia: treatment and outcome of 17 pregnancies. Eur J Haematol. 2000 Sep;65 (3):165\u20139.","DOI":"10.1034\/j.1600-0609.2000.90214.x"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Barbui T, Vannucchi AM, Buxhofer-Ausch V, et al. Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemia. Blood Cancer J. 2015 Nov 27;5 (11):e369.","DOI":"10.1038\/bcj.2015.94"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Otsuka T, Matsuyama K. Nippon Medical School&apos;s ethical review processes for studies involving human subjects. J Nippon Med Sch. 2024;91 (2):136\u20139.","DOI":"10.1272\/jnms.JNMS.2024_91-216"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Arai K, Sakaguchi M, Yui S, et al. Simultaneous detection of JAK2, CALR, and MPL mutations and quantitation of JAK2 V617F allele burden in myeloproliferative neoplasms using the quenching probe-Tm method in i-densy IS-5320. Int J Lab Hematol. 2022 Dec;44 (6):1102\u201310.","DOI":"10.1111\/ijlh.13938"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Melillo L, Tieghi A, Candoni A, et al. Outcome of 122 pregnancies in essential thrombocythemia patients: a report from the Italian registry. Am J Hematol. 2009 Oct;84 (10):636\u201340.","DOI":"10.1002\/ajh.21504"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Martinelli P, Martinelli V, Agangi A, et al. Interferon alfa treatment for pregnant women affected by essential thrombocythemia: case reports and a review. Am J Obstet Gynecol. 2004 Dec;191 (6):2016\u201320.","DOI":"10.1016\/j.ajog.2004.05.001"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Niittyvuopio R, Juvonen E, Kaaja R, et al. Pregnancy in essential thrombocythaemia: experience with 40 pregnancies. Eur J Haematol. 2004 Dec;73 (6):431\u20136.","DOI":"10.1111\/j.1600-0609.2004.00324.x"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. How J, Leiva O, Bogue T, et al. Pregnancy outcomes, risk factors, and cell count trends in pregnant women with essential thrombocythemia. Leuk Res. 2020 Nov;98:106459.","DOI":"10.1016\/j.leukres.2020.106459"},{"key":"31","doi-asserted-by":"publisher","unstructured":"31. Passamonti F, Randi ML, Rumi E, et al. Increased risk of pregnancy complications in patients with essential thrombocythemia carrying the JAK2 (617V&gt;F) mutation. Blood. 2007 Jul 15;110 (2):485\u20139.","DOI":"10.1182\/blood-2007-01-071068"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Beauverd Y, Radia D, Cargo C, et al. Pegylated interferon alpha-2a for essential thrombocythemia during pregnancy: outcome and safety. A case series. Haematologica. 2016 May;101 (5):e182\u20134.","DOI":"10.3324\/haematol.2015.139691"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Schrickel L, Heidel FH, Sadjadian P, et al. Interferon alpha for essential thrombocythemia during 34 high-risk pregnancies: outcome and safety. J Cancer Res Clin Oncol. 2021 May;147 (5):1481\u201391.","DOI":"10.1007\/s00432-020-03430-4"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Zeeman GG, Cunningham FG, Pritchard JA. The magnitude of hemoconcentration with eclampsia. Hypertens Pregnancy. 2009 May;28 (2):127\u201337.","DOI":"10.1080\/10641950802556092"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Maymon R, Strauss S, Vaknin Z, Weinraub Z, Herman A, Gayer G. Normal sonographic values of maternal spleen size throughout pregnancy. Ultrasound Med Biol. 2006 Dec;32 (12):1827\u201331.","DOI":"10.1016\/j.ultrasmedbio.2006.06.017"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Gayer G, Ben Ely A, Maymon R, Hertz M. Enlargement of the spleen as an incidental finding on CT in post-partum females with fever. Br J Radiol. 2012 Jun;85 (1014):753\u20137.","DOI":"10.1259\/bjr\/92126864"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Turhan AG, Humphries RK, Cashman JD, Cuthbert DA, Eaves CJ, Eaves AC. Transient suppression of clonal hemopoiesis associated with pregnancy in a patient with a myeloproliferative disorder. J Clin Invest. 1988 Jun;81 (6):1999\u20132003.","DOI":"10.1172\/JCI113549"},{"key":"38","doi-asserted-by":"publisher","unstructured":"38. Nakada D, Oguro H, Levi BP, et al. Oestrogen increases haematopoietic stem-cell self-renewal in females and during pregnancy. Nature. 2014 Jan 23;505 (7484):555\u20138.","DOI":"10.1038\/nature12932"},{"issue":"6","key":"39","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.stem.2014.11.002","volume":"15","author":"A Sanchez-Aguilera","year":"2014","unstructured":"39. Sanchez-Aguilera A, Arranz L, Martin-Perez D, et al. Estrogen signaling selectively induces apoptosis of hematopoietic progenitors and myeloid neoplasms without harming steady-state hematopoiesis. Cell Stem Cell. 2014 Dec 4;15 (6):791\u2013804.","journal-title":"Cell Stem Cell","ISSN":"https:\/\/id.crossref.org\/issn\/1934-5909","issn-type":"print"}],"container-title":["Journal of Nippon Medical School"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnms\/93\/4\/93_JNMS.2026_93-411\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T05:29:40Z","timestamp":1787981380000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnms\/93\/4\/93_JNMS.2026_93-411\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1272\/jnms.jnms.2026_93-411","relation":{},"ISSN":["1345-4676","1347-3409"],"issn-type":[{"value":"1345-4676","type":"print"},{"value":"1347-3409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,20]]},"article-number":"JNMS.2026_93-411"}}